Shares of AC Immune rose by double-digits on news that the company, encouraged by new data, now intends to ask drug ...

Using a kind of novel linker technology, the startup is developing versions of incretin and non-incretin therapies that can ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...

The legislation, which is scheduled for a vote Thursday, would send funds directly to health savings accounts paired with ...

An unusual tussle over the availability of funds for Apple Tree’s startups led the firm to seek protection from creditors ...